Kurzfassung

Artrial Fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE) A parallel randomized controlled evaluation of clopidogrel plus aspirin, with factorial evaluation of irbesartan, for the prevention of vascular events, in patients with atrial fibrillation